The incidence of low-expression E-cadherin was higher in cases with lymph node metastasis (64.3%, 36 of 56) than in cases without lymph node metastasis (44.4%, 24 of 54) (p = 0.037). Here, CDH1 is linked to metastatic malignant neoplasm in the lymph nodes.